Advisory Research’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Advisory Research’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,840	Closed	-$1.67M	–	503
2023 Q2	$1.67M	Sell	5,840 -1,765	-23%	-$490K	0.21%	133
2023 Q1	$1.65M	Buy	7,605 +2,469	+48%	+$481K	0.27%	94
2022 Q4	$1.06M	Hold	5,136	–	–	0.1%	158
2022 Q3	$1.43M	Sell	5,136 -4,023	-44%	-$1.02M	0.14%	119
2022 Q2	$1.75M	Buy	+9,159	New	+$1.62M	0.17%	93

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Advisory Research's SWAV Position: Q3 2023 in Review

Advisory Research sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 5,840 shares — an estimated $1.67M sold.

Advisory Research first reported a position in SWAV in Q2 2022 and held it in 5 quarters. The position peaked at $1.75M in Q2 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

Advisory Research reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Advisory Research sold 5,840 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $1.67M.
Advisory Research first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Advisory Research's Shockwave Medical, Inc. Common Stock position peaked at $1.75M in Q2 2022.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.